December 19, 2024 at 12:05 PM
December 11, 2024 at 8:06 AM
In his takeAIM hoodie too. The man has a fucking brand
November 22, 2024 at 11:14 PM
In his takeAIM hoodie too. The man has a fucking brand
My year as an @acutemedicine.bsky.social takeAIM fellow came to an end at yesterday’s national conference. A joy and a privilege to spread the word about our brilliant specialty. Choosing Acute Med was the best career choice I ever made. Hoping I convinced a few other people to choose it too!
June 6, 2025 at 6:43 PM
My year as an @acutemedicine.bsky.social takeAIM fellow came to an end at yesterday’s national conference. A joy and a privilege to spread the word about our brilliant specialty. Choosing Acute Med was the best career choice I ever made. Hoping I convinced a few other people to choose it too!
Curis Unveils Groundbreaking Data from the TakeAim Leukemia Clinical Trial#United_States#AML#Lexington#Curis#emavusertib
Curis Unveils Groundbreaking Data from the TakeAim Leukemia Clinical Trial
Curis, Inc. shares promising results from the TakeAim Leukemia study on emavusertib, showing substantial effectiveness in R/R AML patients.
third-news.com
December 10, 2024 at 1:32 PM
Curis Unveils Groundbreaking Data from the TakeAim Leukemia Clinical Trial#United_States#AML#Lexington#Curis#emavusertib
Wanna hear a pretty song?
Like “makes you feel alive because there’s still this beauty in the world” and “how am I alive at the same time as this beautiful thing despite statistics saying I shouldn’t” kind of beautiful?
It’s not long.
Enjoy.
#SleepToken #TakeAim
m.youtube.com/watch?v=pNLJ...
Like “makes you feel alive because there’s still this beauty in the world” and “how am I alive at the same time as this beautiful thing despite statistics saying I shouldn’t” kind of beautiful?
It’s not long.
Enjoy.
#SleepToken #TakeAim
m.youtube.com/watch?v=pNLJ...
Sleep Token - Take Aim (Visualiser)
YouTube video by SleepTokenVEVO
m.youtube.com
March 30, 2025 at 3:56 PM
Wanna hear a pretty song?
Like “makes you feel alive because there’s still this beauty in the world” and “how am I alive at the same time as this beautiful thing despite statistics saying I shouldn’t” kind of beautiful?
It’s not long.
Enjoy.
#SleepToken #TakeAim
m.youtube.com/watch?v=pNLJ...
Like “makes you feel alive because there’s still this beauty in the world” and “how am I alive at the same time as this beautiful thing despite statistics saying I shouldn’t” kind of beautiful?
It’s not long.
Enjoy.
#SleepToken #TakeAim
m.youtube.com/watch?v=pNLJ...
Are you an acute medicine registrar? Keen to spread the word on why it's the best specialty? Want the ultimate leadership and networking opportunity?
Well, you should think about joining takeAIM!
We are currently recruiting for 3 new takeAIM fellows.
You won't regret it!
Well, you should think about joining takeAIM!
We are currently recruiting for 3 new takeAIM fellows.
You won't regret it!
September 5, 2025 at 5:07 PM
Are you an acute medicine registrar? Keen to spread the word on why it's the best specialty? Want the ultimate leadership and networking opportunity?
Well, you should think about joining takeAIM!
We are currently recruiting for 3 new takeAIM fellows.
You won't regret it!
Well, you should think about joining takeAIM!
We are currently recruiting for 3 new takeAIM fellows.
You won't regret it!
I had an inspiring day yesterday at Smith Institute's TakeAIM 2025 Awards. It was an honour to be named a finalist alongside such fantastic research in mathematics and data science. Congratulations to the winner and all involved!
March 20, 2025 at 3:44 PM
I had an inspiring day yesterday at Smith Institute's TakeAIM 2025 Awards. It was an honour to be named a finalist alongside such fantastic research in mathematics and data science. Congratulations to the winner and all involved!
Todays Gear:
☆ DistressedLSTop
☆ TakeAim
☆ InTheBag (Debatable)
💜 Mars and Moon Aligned In Capricorn. Time To Get Real and Examine Motivations... blahblahblah, I Just Caught a $500 Traffic Ticket, Yallz!
Bog Fuuuk!
*deep sigh*
*collects self*
So Yeah, Lets Improvise and Adapt Our Vibes, Babes! xxx 💜
☆ DistressedLSTop
☆ TakeAim
☆ InTheBag (Debatable)
💜 Mars and Moon Aligned In Capricorn. Time To Get Real and Examine Motivations... blahblahblah, I Just Caught a $500 Traffic Ticket, Yallz!
Bog Fuuuk!
*deep sigh*
*collects self*
So Yeah, Lets Improvise and Adapt Our Vibes, Babes! xxx 💜
January 11, 2024 at 2:51 PM
Todays Gear:
☆ DistressedLSTop
☆ TakeAim
☆ InTheBag (Debatable)
💜 Mars and Moon Aligned In Capricorn. Time To Get Real and Examine Motivations... blahblahblah, I Just Caught a $500 Traffic Ticket, Yallz!
Bog Fuuuk!
*deep sigh*
*collects self*
So Yeah, Lets Improvise and Adapt Our Vibes, Babes! xxx 💜
☆ DistressedLSTop
☆ TakeAim
☆ InTheBag (Debatable)
💜 Mars and Moon Aligned In Capricorn. Time To Get Real and Examine Motivations... blahblahblah, I Just Caught a $500 Traffic Ticket, Yallz!
Bog Fuuuk!
*deep sigh*
*collects self*
So Yeah, Lets Improvise and Adapt Our Vibes, Babes! xxx 💜
Verkkotunnus: huntersmarket.fi
Rekisteröity: 2026-09-15 16:19
Käyttäjä: TakeAim ApS
Maa: Tanska
Välittäjä: One.com
Rekisteröity: 2026-09-15 16:19
Käyttäjä: TakeAim ApS
Maa: Tanska
Välittäjä: One.com
September 15, 2026 at 10:11 PM
Verkkotunnus: huntersmarket.fi
Rekisteröity: 2026-09-15 16:19
Käyttäjä: TakeAim ApS
Maa: Tanska
Välittäjä: One.com
Rekisteröity: 2026-09-15 16:19
Käyttäjä: TakeAim ApS
Maa: Tanska
Välittäjä: One.com
Curis Achieves Important Milestone in TakeAim CLL Clinical Trial for Advancing Cancer Treatment#USA#Lexington#Curis#emavusertib#TakeAim_CLL
Curis Achieves Important Milestone in TakeAim CLL Clinical Trial for Advancing Cancer Treatment
Curis, Inc. has successfully dosed the first five patients in its groundbreaking TakeAim CLL study with emavusertib, aimed at enhancing Chronic Lymphocytic Leukemia treatment.
third-news.com
July 30, 2026 at 12:28 PM
Curis Achieves Important Milestone in TakeAim CLL Clinical Trial for Advancing Cancer Treatment#USA#Lexington#Curis#emavusertib#TakeAim_CLL
#CRIS Curis Doses First Five Patients in TakeAim CLL Study
https://www.stocktitan.net/news/CRIS/curis-doses-first-five-patients-in-take-aim-cll-auysbmiyylmb.html
https://www.stocktitan.net/news/CRIS/curis-doses-first-five-patients-in-take-aim-cll-auysbmiyylmb.html
Curis Doses First Five Patients in TakeAim CLL Study
Curis (NASDAQ: CRIS) reported an enrollment milestone in its TakeAim CLL study evaluating emavusertib, an oral IRAK4/FLT3 inhibitor, in Chronic Lymphocytic Leukemia. The company has now dosed the first five patients, after previously opening 11 sites and consenting 10 patients.Curis reaffirmed its expectation to present initial data from 5–10 CLL patients in December 2026. The study combines emavusertib with the BTK inhibitor zanubrutinib to achieve dual NF-kB pathway blockade (BCR and TLR), aiming for deeper responses, complete remissions and undetectable minimal residual disease. According to Curis, the regimen appears well tolerated so far, with possible early signs of deepening responses, although patient numbers remain small.
www.stocktitan.net
July 30, 2026 at 12:00 PM
#CRIS Curis Doses First Five Patients in TakeAim CLL Study
https://www.stocktitan.net/news/CRIS/curis-doses-first-five-patients-in-take-aim-cll-auysbmiyylmb.html
https://www.stocktitan.net/news/CRIS/curis-doses-first-five-patients-in-take-aim-cll-auysbmiyylmb.html
#CRIS Curis Announces Positive Emavusertib Update
https://www.stocktitan.net/news/CRIS/curis-announces-positive-emavusertib-ro66es2o33nr.html
https://www.stocktitan.net/news/CRIS/curis-announces-positive-emavusertib-ro66es2o33nr.html
Curis Announces Positive Emavusertib Update
Curis (NASDAQ: CRIS) reported updated clinical data for emavusertib (CA-4948) in Primary CNS Lymphoma (PCNSL) from the TakeAim Lymphoma study and updated enrollment guidance for the TakeAim CLL Phase 2 study, and will host a webcast on July 22, 2026 at 8:30 a.m. ET.In PCNSL as of July 1, 2026, BTK inhibitor (BTKi)-naïve patients showed a 100% objective response rate (ORR) in 5 of 5 evaluable patients and 86% ORR in all 7 patients, compared with 71% (5 of 7) in prior data as of May 1, 2025. BTKi-experienced patients demonstrated a 33% ORR in 10 of 30 evaluable patients and 26% ORR in all 39 patients, versus 27% (7 of 26) previously.For TakeAim CLL, Curis disclosed that 10 patients have now been consented, with the first five expected to be dosed by the end of July 2026. The company increased its year-end 2026 data guidance from 5 patients to 5–10 patients.
www.stocktitan.net
July 22, 2026 at 11:00 AM
#CRIS Curis Announces Positive Emavusertib Update
https://www.stocktitan.net/news/CRIS/curis-announces-positive-emavusertib-ro66es2o33nr.html
https://www.stocktitan.net/news/CRIS/curis-announces-positive-emavusertib-ro66es2o33nr.html
Preliminary TakeAim data shows promise of #emavusertib in higher-risk #MDS #ASH24 #ASHthrowback
sohoinsider.com/meetings-con...
sohoinsider.com/meetings-con...
SOHO Insider Emavusertib Shows Promise in High-Risk MDS
Emavusertib yields remissions in high-risk MDS with spliceosome mutations, per ASH 2023 TakeAim trial data."
sohoinsider.com
April 22, 2025 at 5:25 PM
Preliminary TakeAim data shows promise of #emavusertib in higher-risk #MDS #ASH24 #ASHthrowback
sohoinsider.com/meetings-con...
sohoinsider.com/meetings-con...
Feed: "Clinical Trials Arena"
By: Salong Debbarma on Monday, June 29, 2026
By: Salong Debbarma on Monday, June 29, 2026
Curis opens 11 sites for emavusertib combo in TakeAim CLL trial
Curis has opened enrolment at 11 clinical sites for its Phase II TakeAim CLL trial, assessing the oral small molecule inhibitor emavusertib along with zanubrutinib for patients with CLL.
www.clinicaltrialsarena.com
June 30, 2026 at 1:51 AM
Feed: "Clinical Trials Arena"
By: Salong Debbarma on Monday, June 29, 2026
By: Salong Debbarma on Monday, June 29, 2026
It didn’t blow up, so I am taking aim again, at accountable parties. For this always was, The Game of Accountability. Been playing since 1st May 2024, and am stuck in a song. #negligence #invisiblemassgrave #lawless #godless #hopeless #FIGHT #takeaim #accountability #THELAW youtu.be/f3u0jce1U1c?...
The Heavy Horses - Pale Rider (Lyric Video)
YouTube video by Blue i
youtu.be
December 15, 2025 at 3:53 AM
It didn’t blow up, so I am taking aim again, at accountable parties. For this always was, The Game of Accountability. Been playing since 1st May 2024, and am stuck in a song. #negligence #invisiblemassgrave #lawless #godless #hopeless #FIGHT #takeaim #accountability #THELAW youtu.be/f3u0jce1U1c?...